About the Authors
- Nguyen Thi Ngoc Lan
-
Affiliation Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam
- Nguyen Thi Nguyet Thu
-
Affiliation Pasteur Institute, Ho Chi Minh City, Vietnam
- Aurélie Barrail-Tran
-
Affiliations Clinical Pharmacy Department, Bicêtre Hospital, Assistance-Publique Hôpitaux de Paris, Kremlin-Bicêtre, France, Clinical Pharmacy and Pharmacokinetics Department (EA4123), University Paris Sud, Chatenay Malabry, France
- Nguyen Hong Duc
-
Affiliation Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam
- Nguyen Ngoc Lan
-
Affiliation Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam
- Didier Laureillard
-
Affiliation ANRS, Ho Chi Minh City, Vietnam
- Truong Thi Xuan Lien
-
Affiliation Pasteur Institute, Ho Chi Minh City, Vietnam
- Laurence Borand
-
Affiliation Epidemiology and Public Health Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia
- Catherine Quillet
-
Affiliation ANRS, Ho Chi Minh City, Vietnam
- Catherine Connolly
-
Affiliation Biostatistics Unit, Medical Research Council, Durban, South Africa
- Dominique Lagarde
-
Affiliation The International Union Against Tuberculosis and Lung Diseases, Paris, France
- Alexander Pym
-
Affiliations TB Research Unit, Medical Research Council, Durban, South Africa, KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH), South Africa
- Christian Lienhardt
-
Affiliation World Health Organization Stop Tuberculosis Program, Geneva, Switzerland
- Nguyen Huy Dung
-
Affiliation Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam
- Anne-Marie Taburet
-
Affiliation Clinical Pharmacy Department, Bicêtre Hospital, Assistance-Publique Hôpitaux de Paris, Kremlin-Bicêtre, France
- Anthony D Harries
-
* E-mail: adharries@theunion.org
Affiliations The International Union Against Tuberculosis and Lung Diseases, Paris, France, London School of Hygiene and Tropical Medicine, London, United Kingdom
Competing Interests
The authors declare that the French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Institut national de la santé et de la recherche médicale-Agence Nationale de Recherche sur le Sida) was the Sponsor and Funder of the study. Fondation Total also provided a grant to support the study. The authors also declare that they received a donation of rifabutin from Laboratoires SERB and a donation of rifabutin and 25-O-desacetyl rifabutin reference powder from Pfizer (SA) which was used for the preparation of standard curves and quality control of assays. The French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (INSERM-ANRS), Fondation Total, Laboratoires SERB and Pfizer (SA) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Furthermore, receipt of the donations from Laboratoires SERB and Pfizer (SA) does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: NTNL D. Laureillard D. Lagarde AP CL ADH. Performed the experiments: NTNL NTNT ABT NHD NNL TTXL NHD. Analyzed the data: NTNT ABT AMT D. Laureillard LB CQ CC D. Lagarde. Wrote the paper: NTNL NTNT ABT NHD NNL D. Laureillard TTXL LB CQ CC D. Lagarde AP CL NHD AMT ADH. Wrote the first draft of the manuscript: AMT D. Lagarde ADH. ICMJE criteria for authorship read and met: NTNL NTNT ABT NHD NNL D. Laureillard TTXL LB CQ CC D. Lagarde AP CL NHD AMT ADH. Agree with manuscript results and conclusions: NTNL NTNT ABT NHD NNL D. Laureillard TTXL LB CQ CC D. Lagarde AP CL NHD AMT ADH.